Galaxy Medicare Limited

Galaxy Medicare Limited (GML) is a micro-cap Healthcare company valued at ₹29 crore operating in Medical Equipment & Supplies on the NSE and BSE.

Recent price move

Galaxy Medicare Limited last traded at ₹17.8, modestly down 1.66% on the day.

Recent developments

On 2026-03-31, the company reported its latest financial results, showing a decline in both revenue and net profit compared to the same quarter a year earlier. The company has not paid dividends despite reporting profits, which may indicate retention of earnings for reinvestment.

Financial performance

The company's annual revenue grew 2.9% to ₹40 crore, but net profit rose only 1.5% to ₹3 crore. The latest quarter saw revenue fall 3.1% year-on-year to ₹21 crore and net profit drop 15.7% to ₹1 crore, while the net profit margin narrowed 0.1 percentage points to 8.5%.

Valuation multiples

The stock trades at 7.9 times earnings, a discount to the Healthcare median of 32.0, 0.73 times book value. It yields 4.3%.

Things to watch

The company's latest quarter net profit fell 15.7% year-on-year, and the net profit margin narrowed. The stock is 40.7% below its 52-week high, and the company has not distributed dividends to shareholders despite reporting profits.

Where it stands

Galaxy Medicare Limited ended the latest quarter with revenue of ₹21 crore and net profit of ₹1 crore, both down compared to the same quarter a year earlier. The stock is 40.7% below its 52-week high, and the company has not paid dividends despite reporting profits.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.